FDA approves ensitrelvir for COVID-19 postexposure prophylaxis following phase 3 data showing efficacy against Omicron symptoms. The FDA recently approved ensitrelvir (Xocova; Shionogi), an ...
PrEP and PEP are important HIV prevention tools that hospitalists should understand and discuss with patients during hospital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results